Vertex Gmbh

Vertex Gmbh company information, Employees & Contact Information

Explore related pages

Related company profiles:

VERTEX is a purely private, 100% self-financed, owner-managed Austrian company not affiliated with any group. From our many years of experience in the logistics sector, we know what our partners expect from us: Service of the highest quality, which are geared to the respective individual requirements and preferences. Our aim is to meet the high expectations of our partners stay in and day out.

Company Details

Employees
118
Founded
-
Address
Lofererstraße 33, Kirchbichl,tirol 6322,austria
Industry
Truck Transportation
NAICS
Truck Transportation
General Freight Trucking
Specialized Freight Trucking
General Freight Trucking, Local
General Freight Trucking, Long-Distance
Used Household and Office Goods Moving
Specialized Freight (except Used Goods) Trucking, Local
Specialized Freight (except Used Goods) Trucking, Long-Distance
General Freight Trucking, Long-Distance, Truckload
General Freight Trucking, Long-Distance, Less Than Truckload
Website
vertex.at
HQ
Kirchbichl, Tirol
Looking for a particular Vertex Gmbh employee's phone or email?

Vertex Gmbh Questions

News

Vertex to Participate in the UBS Global Healthcare Conference on November 11 - Business Wire

Vertex to Participate in the UBS Global Healthcare Conference on November 11 Business Wire

Vertex to Announce Third Quarter 2025 Financial Results on Monday, November 3, 2025 - GlobeNewswire

Vertex to Announce Third Quarter 2025 Financial Results on Monday, November 3, 2025 GlobeNewswire

Vertex at Morgan Stanley Conference: Strategic Pipeline Expansion - Investing.com

Vertex at Morgan Stanley Conference: Strategic Pipeline Expansion Investing.com

Vertex to Present at Goldman Sachs Communacopia + Technology Conference - Yahoo Finance

Vertex to Present at Goldman Sachs Communacopia + Technology Conference Yahoo Finance

Q3 '25 Results: Vertex to Release Third Quarter 2025 Financial Results Nov. 3; investor call & webcast - Stock Titan

Q3 '25 Results: Vertex to Release Third Quarter 2025 Financial Results Nov. 3; investor call & webcast Stock Titan

David Altshuler, geneticist who helped transform Vertex, to retire next year - BioPharma Dive

David Altshuler, geneticist who helped transform Vertex, to retire next year BioPharma Dive

Inside Vertex 3.0: Can Reshma Kewalramani repeat one of biotech's biggest success stories 'again and again and again'? - Endpoints News

Inside Vertex 3.0: Can Reshma Kewalramani repeat one of biotech's biggest success stories 'again and again and again'? Endpoints News

Syria signs US$300m agreement with Iraq’s Vertex to expand Hama Cement plant - International Cement Review

Syria signs US$300m agreement with Iraq’s Vertex to expand Hama Cement plant International Cement Review

Vertex to sunset VRTX token, migrate DEX to Kraken-backed Layer 2 Ink - theblock.co

Vertex to sunset VRTX token, migrate DEX to Kraken-backed Layer 2 Ink theblock.co

Vertex to Announce Third Quarter 2025 Financial Results on November 3rd - Business Wire

Vertex to Announce Third Quarter 2025 Financial Results on November 3rd Business Wire

Vertex at Wells Fargo Conference: Strategic Growth and Challenges - Investing.com

Vertex at Wells Fargo Conference: Strategic Growth and Challenges Investing.com

Vertex to Participate in Upcoming September Investor Conferences - Business Wire

Vertex to Participate in Upcoming September Investor Conferences Business Wire

Vertex at Bank of America Conference: Strategic Drug Developments - Investing.com

Vertex at Bank of America Conference: Strategic Drug Developments Investing.com

Vertex at Goldman Sachs Conference: Strategic Moves in E-Invoicing and AI - Investing.com

Vertex at Goldman Sachs Conference: Strategic Moves in E-Invoicing and AI Investing.com

Vertex at Needham Conference: Strategic Growth and Innovation - Investing.com

Vertex at Needham Conference: Strategic Growth and Innovation Investing.com

Vertex at ADA 85th Scientific Sessions: Promising Diabetes Breakthrough - Investing.com

Vertex at ADA 85th Scientific Sessions: Promising Diabetes Breakthrough Investing.com

Vertex at Bernstein Conference: Strategic Growth and Innovation - Investing.com

Vertex at Bernstein Conference: Strategic Growth and Innovation Investing.com

Vertex at Leerink: Strategic Moves and Growth Prospects - Investing.com

Vertex at Leerink: Strategic Moves and Growth Prospects Investing.com

ToolGen Files Patent Infringement Lawsuit Against Vertex in the United Kingdom - PR Newswire

ToolGen Files Patent Infringement Lawsuit Against Vertex in the United Kingdom PR Newswire

Vertex On Track To Significantly Improve Revenue And Earnings By 2030 (NASDAQ:VRTX) - Seeking Alpha

Vertex On Track To Significantly Improve Revenue And Earnings By 2030 (NASDAQ:VRTX) Seeking Alpha

Vertex to Announce First Quarter 2025 Financial Results on Wednesday, May 7, 2025 - GlobeNewswire

Vertex to Announce First Quarter 2025 Financial Results on Wednesday, May 7, 2025 GlobeNewswire

Vertex to manufacture gene therapies in New Hampshire - The Business Journals

Vertex to manufacture gene therapies in New Hampshire The Business Journals

Save the Date: Tax Software Leader Vertex Sets Q2 2025 Earnings Release for August 6 - Stock Titan

Save the Date: Tax Software Leader Vertex Sets Q2 2025 Earnings Release for August 6 Stock Titan

State of Vertex Q4 2024 - Messari

State of Vertex Q4 2024 Messari

Vertex to lay off 125 employees in R.I., consolidate offices - The Boston Globe

Vertex to lay off 125 employees in R.I., consolidate offices The Boston Globe

Egocentric neural representation of geometric vertex in the retrosplenial cortex - Nature

Egocentric neural representation of geometric vertex in the retrosplenial cortex Nature

Monotech launches PixelGlow Vertex at Printpack 25 - Indian Printer & Publisher

Monotech launches PixelGlow Vertex at Printpack 25 Indian Printer & Publisher

Kissht Files DRHP For Rs 1,000 Cr IPO, Vertex To Sell Stake - BW Disrupt

Kissht Files DRHP For Rs 1,000 Cr IPO, Vertex To Sell Stake BW Disrupt

Vertex to buy Alpine Immune Sciences for $4.9 billion - statnews.com

Vertex to buy Alpine Immune Sciences for $4.9 billion statnews.com

Vertex to buy kidney disease drugmaker Alpine for $4.9B - BioPharma Dive

Vertex to buy kidney disease drugmaker Alpine for $4.9B BioPharma Dive

Vectrus and Vertex to Combine, Creating a Global Leader in Mission-Essential Solutions - PR Newswire

Vectrus and Vertex to Combine, Creating a Global Leader in Mission-Essential Solutions PR Newswire

Vertex to Buy Kidney Disease Drug Developer for $4.9 Billion - Bloomberg.com

Vertex to Buy Kidney Disease Drug Developer for $4.9 Billion Bloomberg.com

Vectrus to merge with Vertex in a deal valuing Vertex at $2.1 billion - MarketWatch

Vectrus to merge with Vertex in a deal valuing Vertex at $2.1 billion MarketWatch

Vertex to Acquire Alpine Immune Sciences for $4.9B, Broadening Kidney Drug Pipeline - Genetic Engineering and Biotechnology News

Vertex to Acquire Alpine Immune Sciences for $4.9B, Broadening Kidney Drug Pipeline Genetic Engineering and Biotechnology News

General, open-source vertex modeling in biological applications using Tissue Forge - Nature

General, open-source vertex modeling in biological applications using Tissue Forge Nature

Vertex To Acquire Pagero For $555 Million - citybiz

Vertex To Acquire Pagero For $555 Million citybiz

Vertex will stay at Fan Pier HQ after mulling possible move - The Business Journals

Vertex will stay at Fan Pier HQ after mulling possible move The Business Journals

LinkedIn post lands Vertex in hot water with MHRA over breach of UK ad regulations - Fierce Pharma

LinkedIn post lands Vertex in hot water with MHRA over breach of UK ad regulations Fierce Pharma

Sionna raises another $182M to challenge Vertex in cystic fibrosis - BioPharma Dive

Sionna raises another $182M to challenge Vertex in cystic fibrosis BioPharma Dive

Vertex to tackle liver disease with Verve, putting up $60M to partner on gene editing program - Fierce Biotech

Vertex to tackle liver disease with Verve, putting up $60M to partner on gene editing program Fierce Biotech

Vertex to Acquire ViaCyte for $320M, Growing Diabetes Cell Therapy Pipeline - Genetic Engineering and Biotechnology News

Vertex to Acquire ViaCyte for $320M, Growing Diabetes Cell Therapy Pipeline Genetic Engineering and Biotechnology News

Esteemed Harvard Researcher Heads to Vertex to Curate Diabetes Portfolio - BioSpace

Esteemed Harvard Researcher Heads to Vertex to Curate Diabetes Portfolio BioSpace

Latigo, running behind Vertex in non-opioid pain race, raises $135M to catch up - Fierce Biotech

Latigo, running behind Vertex in non-opioid pain race, raises $135M to catch up Fierce Biotech

Vertex passes neuropathic pain test, teeing up pivotal trials in pursuit of blockbuster opportunity - Fierce Biotech

Vertex passes neuropathic pain test, teeing up pivotal trials in pursuit of blockbuster opportunity Fierce Biotech

Arbor and Vertex to Advance Reverse Transcriptase Genetic Medicines - Genetic Engineering and Biotechnology News

Arbor and Vertex to Advance Reverse Transcriptase Genetic Medicines Genetic Engineering and Biotechnology News

Alum Leads SPH Affinity Group at Vertex Pharmaceuticals - Boston University

Alum Leads SPH Affinity Group at Vertex Pharmaceuticals Boston University

Doug Melton to reunite with his Semma collaborators at Vertex to develop 'curative cell therapies' - Endpoints News

Doug Melton to reunite with his Semma collaborators at Vertex to develop 'curative cell therapies' Endpoints News

Vertex to Buy Raytheon’s Defense Training & Mission Critical Solutions Unit; Ed Boyington Quoted - GovCon Wire

Vertex to Buy Raytheon’s Defense Training & Mission Critical Solutions Unit; Ed Boyington Quoted GovCon Wire

Dominant role of two-photon vertex in nonlinear response in two-dimensional Dirac systems - Nature

Dominant role of two-photon vertex in nonlinear response in two-dimensional Dirac systems Nature

Vertex to buy preclinical biotech for $950M, searching a Type 1 diabetes cure - BioPharma Dive

Vertex to buy preclinical biotech for $950M, searching a Type 1 diabetes cure BioPharma Dive

Vertex to transform customer experience for Indian MSMEs - varindia.com

Vertex to transform customer experience for Indian MSMEs varindia.com

Editor’s Note: Goodbye, Vertex (Published 2024) - The New York Times

Editor’s Note: Goodbye, Vertex (Published 2024) The New York Times

Tevard Biosciences announces collaboration with Vertex to develop novel tRNA-based therapies for Duchenne muscular dystrophy - PR Newswire

Tevard Biosciences announces collaboration with Vertex to develop novel tRNA-based therapies for Duchenne muscular dystrophy PR Newswire

Vertex to Present Phase 3 Data Highlighting Suzetrigine’s Potential as a First-in-Class, Highly Selective Pain Signal Inhibitor at the American Society of Anesthesiologists Annual Meeting - Business Wire

Vertex to Present Phase 3 Data Highlighting Suzetrigine’s Potential as a First-in-Class, Highly Selective Pain Signal Inhibitor at the American Society of Anesthesiologists Annual Meeting Business Wire

Douglas Melton, noted stem cell researcher, leaves Harvard for Vertex to create diabetes treatments - statnews.com

Douglas Melton, noted stem cell researcher, leaves Harvard for Vertex to create diabetes treatments statnews.com

King of Prussia's Vertex to buy Austrian company for up to $180M - The Business Journals

King of Prussia's Vertex to buy Austrian company for up to $180M The Business Journals

Vertex to expand autoimmune and inflammatory disease pipeline with $4.9bn Alpine acquisition - PMLiVE

Vertex to expand autoimmune and inflammatory disease pipeline with $4.9bn Alpine acquisition PMLiVE

Entrepreneur Marc Braterman pauses advisory boutique Vertex to find new leader - TheBusinessDesk.com

Entrepreneur Marc Braterman pauses advisory boutique Vertex to find new leader TheBusinessDesk.com

Vertex to Present at Citi 2023 Global Technology Conference - Stock Titan

Vertex to Present at Citi 2023 Global Technology Conference Stock Titan

Varjo & Vertex partner to provide XR training for US Air Force - Auganix.org

Varjo & Vertex partner to provide XR training for US Air Force Auganix.org

Vertex to shutter Canada site, focus in on 3 hubs in R&D shuffle - Fierce Pharma

Vertex to shutter Canada site, focus in on 3 hubs in R&D shuffle Fierce Pharma

Vertex’s David Altshuler Humanizes Drug Discovery - Genetic Engineering and Biotechnology News

Vertex’s David Altshuler Humanizes Drug Discovery Genetic Engineering and Biotechnology News

Vertex Announces CEO Succession Plan for 2012 - Vertex Pharmaceuticals

Vertex Announces CEO Succession Plan for 2012 Vertex Pharmaceuticals

Interview - Don Cochrane, Founder of VERTEX Watches - Monochrome Watches

Interview - Don Cochrane, Founder of VERTEX Watches Monochrome Watches

Vertex to invest $33 million in Cartagena biomethane plant: reports - Quantum Commodity Intelligence

Vertex to invest $33 million in Cartagena biomethane plant: reports Quantum Commodity Intelligence

(PDF) The Maximum-Level Vertex in an Arrangement of Lines - researchgate.net

(PDF) The Maximum-Level Vertex in an Arrangement of Lines researchgate.net

Filings Reveal Concert Pharma Spurned $250 Million Buyout Offer From Vertex in November 2016 - BioSpace

Filings Reveal Concert Pharma Spurned $250 Million Buyout Offer From Vertex in November 2016 BioSpace

L-3 Vertex to provide ADS-B avionics upgrades for Navy TH-57 Sea Ranger training helicopters - Military Aerospace

L-3 Vertex to provide ADS-B avionics upgrades for Navy TH-57 Sea Ranger training helicopters Military Aerospace

Festival glamping? Madison House Presents gives it a spin for Vertex in Buena Vista - The Denver Post

Festival glamping? Madison House Presents gives it a spin for Vertex in Buena Vista The Denver Post

Vertex appoints Ludovic Fenaux as Senior Vice President, International Commercial Operations - Pf Media

Vertex appoints Ludovic Fenaux as Senior Vice President, International Commercial Operations Pf Media

Vertex to stop selling hepatitis C drug Incivek - The Boston Globe

Vertex to stop selling hepatitis C drug Incivek The Boston Globe

Drug maker Vertex names new CEO - Boston Herald

Drug maker Vertex names new CEO Boston Herald

Liquid restaurant Vertex at Fairfield by Marriott Kolkata unveils new menu - Indiablooms

Liquid restaurant Vertex at Fairfield by Marriott Kolkata unveils new menu Indiablooms

Top Vertex Gmbh Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant